Back to Search
Start Over
NEW DRUGS
- Source :
- Drug Topics. February 19, 2001, Vol. 145 Issue 4, 57
- Publication Year :
- 2001
-
Abstract
- Organon Inc., West Orange, N.J., (800) 241-8812, has received FDA approval for Cyclessa (desogestrel/ethinyl estradiol oral contraceptive), the first low-dose (less than 30 mcg of estrogen) triphasic contraceptive. Cyclessa is [...]
- Subjects :
- United States. Food and Drug Administration -- Laws, regulations and rules
Organon Inc. -- Product introduction -- Laws, regulations and rules
Salix Pharmaceuticals -- Product introduction
Axcan Scandipharm Inc. -- Product introduction
Schering-Plough Corp. -- Product introduction -- Laws, regulations and rules
Enzon Pharmaceuticals Inc. -- Product introduction -- Laws, regulations and rules
Hepatitis -- Laws, regulations and rules
Antiviral agents -- Product introduction
Contraceptives industry -- Product introduction
Pharmaceutical industry -- Product introduction
Oral contraceptives -- Product introduction
Government regulation
Business
Pharmaceuticals and cosmetics industries
Cyclessa (Contraceptive) -- Product introduction
Colazal (Medication) -- Product introduction
Canasa (Medication) -- Product introduction
Peg-Intron (Medication) -- Product introduction
Subjects
Details
- Language :
- English
- ISSN :
- 00126616
- Volume :
- 145
- Issue :
- 4
- Database :
- Gale General OneFile
- Journal :
- Drug Topics
- Publication Type :
- Periodical
- Accession number :
- edsgcl.70888099